Skip to main content

Advertisement

ADVERTISEMENT

The Need for Longer-Lasting PAD Solutions With DCB Technology | Chapter II

 

This program outlines the essential need for longer-lasting peripheral arterial disease (PAD) solutions for complex lesions using drug-coated balloon therapy. Join us for this live, 60-minute panel discussion with leading physician experts describing the latest safety data and their continued practice with the Lutonix™ Drug-Coated Balloon Platform. Highlights include:

  • The Latest Safety on Paclitaxel: SWEDEPAD, presented by the National Principal Investigator
  • Drug-Eluting Therapy: The Critical Role It Plays in Everyday PAD Practice
  • Real-World Case Applications With Lutonix™ DCB

Andrej Schmidt

 

 

Andrej Schmidt, MD
​​​​​​Interventional Cardiologist and Angiolist, Department of Angiology, University Hospital, Leipzig, Germany;

 

 

houthoofd

 

 

Sabrina Houthoofd, MD
​​​​​Vascular Surgeon, Universitair Ziekenhuis, Leuven, Belgium

 

 

Falk

 

 

Marten Falkenberg, MD
​​​​​​Vascular Surgeon, Department of Radiology, Sahlgrenska University Hospital, Gothenburg, Sweden

 

 

Nord

 

 

Joakim Nordanstig, MD
​​​​​Senior Vascular Surgeon, Vascular Researcher, Sahlgrenska University Hospital, Gothenburg, Sweden

 

 

Yvonne Bausback

 

 

Yvonne Bausback, MD
​​​​​Interventional Cardiologist and Angiologist, Department of Angiology, University Hospital, Leipzig, Germany

Advertisement

Advertisement

Advertisement